EUCTR2015-000177-12-Outside-EU/EEA进行中（未招募）不适用
An Observer-Blind, Randomized, Comparator-Controlled, Single-Centre Study to Evaluate the Tolerability, Safety, and Immunogenicity of Inactivated Influenza Vaccine, CSL Limited in a Healthy Pediatrics and Adult Population (aged =>3 years to =< 80 years)
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- CSL Limited
- 入组人数
- 720
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Healthy subjects aged =>3 years to =< 80 years. Be able to provide a pre and post vaccination sample of up to 3 mL of venous blood. Females of reproductive age who are not pregnant must agree to use contraception.
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 270
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 300
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 150
排除标准
- •Hypersensitivity to eggs, chicken protein, neomycin, polymyxin or any components of the vaccine. Influenza vaccination in the previous 6 months. Clinical signs of active infection and/or an axillary temperature of =>37.1°C at study entry. Vaccination with a registered vaccine within 14 days (for inactivated vaccines) or 28 days (for live vaccines) prior to receiving Study Vaccine.
研究者
相似试验
进行中（未招募）
1 期
A clinical trial to investigate a plant-derived flu vaccine in adults 65 years of age and older in order to assess efficacy, safety and to see how well it works at generating an immune response.Seasonal influenzaMedDRA version: 20.0 Level: PT Classification code 10022000 Term: Influenza System Organ Class: 10021881 - Infections and infestationsEUCTR2018-001894-26-DEMedicago R&D Inc.12,000
进行中（未招募）
1 期
A clinical trial to investigate a plant-derived flu vaccine in adults 65 years of age and older in order to assess efficacy, safety and to see how well it works at generating an immune response.Seasonal influenzaMedDRA version: 20.0 Level: PT Classification code 10022000 Term: Influenza System Organ Class: 10021881 - Infections and infestationsEUCTR2018-001894-26-FIMedicago R&D Inc.12,120
已完成
1 期
To evaluate the safety and efficacy of facial bleaches on healthy human subjects.CTRI/2018/01/011379Dabur India Ltd220
已完成
2 期
A Randomized, Active-comparator, Observer-blind, Phase I/II/III Study to Demonstrate the Immunogenicity of a Single Booster Dose of DS-5670a in Adults and Elderly Received a Primary Series of Approved COVID-19 VaccineJPRN-jRCT2071210106Inoguchi Akihiro5,028
招募中
3 期
A clinical study to assess immunogenicity and safety of diphtheria, tetanus, pertussis, hepatitis B,polio and Haemophilus influenzae combination vaccine in young childreCTRI/2024/04/066095Serum Institute of India Pvt Ltd